The global varicose vein treatment market size was valued at USD 1.74 billion in 2025 and is projected to grow from USD 1.84 billion in 2026 to USD 2.95 billion by 2034 at a CAGR of 6.05% during the forecast period 2026-2034. North America dominated the varicose vein treatment market with a market share of 38.6% in 2025.
Varicose vein treatment refers to medical procedures and therapies used to manage enlarged, twisted veins caused by weakened or damaged vein valves, most commonly in the legs. Treatment options include compression therapy, sclerotherapy, endovenous laser therapy (EVLT), radiofrequency ablation (RFA), vein stripping, and minimally invasive procedures. The growing prevalence of venous disorders, aging populations, and increasing preference for minimally invasive treatments are driving the growth of the varicose vein treatment market.
Download a Free Sample To learn more about this report,
Growing Preference for Minimally Invasive Vein Treatment Procedures
The varicose vein treatment market trends are increasingly driven by the growing adoption of minimally invasive procedures such as endovenous laser ablation (EVLA), radiofrequency ablation (RFA), ultrasound-guided foam sclerotherapy, and medical adhesive closure systems. Compared with conventional vein stripping surgery, these procedures offer shorter recovery times, reduced pain, minimal scarring, and improved clinical outcomes. Rising awareness of chronic venous disease, an aging population, increasing obesity rates, and prolonged sedentary lifestyles are further supporting demand for advanced vein treatment technologies. Healthcare providers are also expanding the use of image-guided interventions that improve treatment precision while enabling outpatient care, contributing to the continued growth of the varicose vein treatment market.
Advancements in Endovenous Ablation Technologies
Another important varicose vein treatment market trend is the continuous innovation in endovenous ablation technologies aimed at improving procedural efficiency and long-term patient outcomes. Manufacturers are introducing advanced catheter systems, improved energy delivery technologies, and next-generation closure devices to enhance physician confidence and reduce treatment complications. Clinical studies are also evaluating newer ablation techniques to provide comparable or superior outcomes while minimizing patient discomfort. These technological advancements are encouraging wider adoption of minimally invasive vein treatments across hospitals, specialty clinics, and ambulatory surgical centers.
Rising Prevalence of Chronic Venous Disorders and Aging Population
The varicose vein treatment market is driven by the increasing prevalence of chronic venous disorders, an aging global population, and rising obesity rates. Sedentary lifestyles, prolonged standing, and genetic predisposition are contributing to the growing incidence of varicose veins, increasing demand for effective treatment options. Healthcare providers are increasingly adopting minimally invasive procedures such as endovenous laser ablation, radiofrequency ablation, and sclerotherapy due to their faster recovery times and improved patient outcomes. Growing awareness of venous health is further supporting market growth.
High Treatment Costs and Limited Reimbursement
The varicose vein treatment market faces restraints due to the high cost of advanced minimally invasive procedures and limited reimbursement coverage in several countries. Many patients delay treatment because varicose vein procedures are often considered cosmetic unless severe symptoms or complications are present. In addition, access to specialized vascular care remains limited in developing regions, restricting the adoption of advanced treatment technologies.
Increasing Adoption of Outpatient and Image-Guided Procedures
The expansion of outpatient vascular care and image-guided minimally invasive procedures presents significant opportunities for the varicose vein treatment market. Hospitals and specialty vein clinics are increasingly performing endovenous treatments in outpatient settings, reducing hospital stays and healthcare costs. Continuous innovation in catheter technologies, medical adhesives, and ultrasound-guided procedures is also improving treatment precision and patient satisfaction, creating new growth opportunities for device manufacturers.
Ensuring Long-Term Treatment Success and Patient Awareness
One of the major challenges facing the varicose vein treatment market is ensuring long-term treatment effectiveness while increasing patient awareness of chronic venous disease. Recurrence of varicose veins after treatment, delayed diagnosis, and low awareness of early symptoms can reduce treatment success. Healthcare providers must also educate patients on lifestyle modifications, compression therapy, and follow-up care to minimize recurrence. These factors continue to influence treatment outcomes and overall market adoption.
Request Customizationto receive a tailored report.
Endovenous Ablation Segment Dominated the Market with 43.5% Share in 2025
The endovenous ablation segment dominated the varicose vein treatment market with a 43.5% market share in 2025, accounting for USD 0.76 billion, and is projected to grow at a CAGR of 7.24% during the forecast period. The segment's dominance is driven by the increasing preference for minimally invasive procedures that offer faster recovery, reduced pain, and improved clinical outcomes compared with conventional surgery. Rising adoption of laser and radiofrequency ablation technologies continues to strengthen the segment's leading position.
The sclerotherapy, ligation, and supportive treatments segments also contribute significantly to the varicose vein treatment market. Sclerotherapy remains widely used for treating smaller varicose and spider veins, while ligation and supportive therapies continue to play an important role in managing chronic venous disorders and improving patient outcomes.
Laser Ablation Devices Segment is Projected to Register the Fastest Growth at a CAGR of 7.55%
The laser ablation devices segment is projected to register the fastest CAGR of 7.55% during 2026–2034. The segment accounted for 17.2% of the market, valued at USD 0.30 billion in 2025. Growth is driven by increasing adoption of minimally invasive laser-based procedures that provide high treatment precision, shorter recovery periods, and lower complication rates. Continuous technological advancements in laser systems and growing patient preference for outpatient procedures are further supporting segment expansion.
The ablation devices, radio frequency ablation or thermal ablation, ultrasound ablation devices, catheters or kits for sclerotherapy & adhesion injections, compression devices, and others segments continue to contribute significantly to the varicose vein treatment market. Growing demand for advanced treatment technologies and improved procedural efficiency continues to support adoption across these product categories.
Hospitals Segment Dominated the Market with 46.7% Share in 2025
The hospitals segment dominated the varicose vein treatment market with a 46.7% market share in 2025, accounting for USD 0.81 billion, and is projected to grow at a CAGR of 6.42% during the forecast period. The segment's leadership is attributed to the availability of advanced vascular treatment technologies, experienced healthcare professionals, and comprehensive diagnostic and post-treatment care. Increasing patient preference for hospital-based minimally invasive procedures continues to strengthen the segment's market position.
The ambulatory surgical centers, specialty clinics, and others segments also contribute significantly to the varicose vein treatment market. Ambulatory surgical centers are witnessing increasing adoption due to cost-effective outpatient procedures, while specialty clinics continue to expand because of their focused expertise in venous disease diagnosis and treatment.
Speak to an Analystto discuss market opportunities.
North America dominated the varicose vein treatment market with a 38.6% share in 2025, accounting for USD 0.67 billion, and is projected to grow at a CAGR of 6.35% during the forecast period. Growth is driven by the high prevalence of chronic venous disorders, increasing adoption of minimally invasive treatment procedures, advanced healthcare infrastructure, and growing awareness of vascular health. The presence of leading medical device manufacturers and favorable reimbursement policies further support regional market growth.
The U.S. market was valued at USD 0.57 billion in 2025, making it the largest contributor in North America. Rising demand for endovenous ablation procedures, increasing obesity rates, growing aging population, and widespread availability of advanced vascular treatment technologies continue to drive market growth.
Canada's market reached USD 0.10 billion in 2025. Increasing awareness of chronic venous disease, expanding access to minimally invasive procedures, improving healthcare infrastructure, and rising adoption of laser and radiofrequency ablation technologies continue to support steady market expansion.
Europe accounted for 29.4% of the varicose vein treatment market, reaching USD 0.51 billion in 2025, and is expected to register a CAGR of 6.18% during the forecast period. Increasing prevalence of venous disorders, growing elderly population, favorable healthcare reimbursement, and rising adoption of advanced endovenous treatment technologies continue to drive regional market growth.
The U.K. market was valued at USD 0.12 billion in 2025. Rising awareness of minimally invasive vein treatments, increasing outpatient procedures, and expanding vascular healthcare services continue to support market growth.
Germany's market accounted for USD 0.15 billion in 2025. Strong healthcare infrastructure, increasing adoption of advanced vein treatment devices, and growing demand for minimally invasive vascular procedures continue to support market expansion.
Asia Pacific held 21.8% of the varicose vein treatment market, valued at USD 0.38 billion in 2025, and is projected to register the fastest CAGR of 7.84% during the forecast period. Rising healthcare expenditure, increasing awareness of venous disorders, growing medical tourism, and expanding access to advanced vascular treatment technologies are driving regional market growth.
Japan's market generated USD 0.09 billion in 2025. The country's aging population, increasing prevalence of chronic venous diseases, and growing adoption of minimally invasive treatment procedures continue to support market growth.
China's market accounted for USD 0.20 billion in 2025, representing the largest share within Asia Pacific. Rapid healthcare infrastructure development, increasing patient awareness, expanding availability of advanced vein treatment technologies, and growing investments in vascular care continue to drive market expansion.
Middle East & Africa accounted for 4.1% of the varicose vein treatment market, totaling USD 0.07 billion in 2025, and is anticipated to grow at a CAGR of 6.29% during the forecast period. Increasing healthcare investments, rising prevalence of lifestyle-related vascular disorders, improving access to minimally invasive treatments, and expanding specialty vascular clinics continue to support regional market growth.
The UAE market was valued at USD 0.02 billion in 2025. Rising investments in advanced healthcare infrastructure, increasing medical tourism, and growing adoption of minimally invasive vein treatment procedures continue to drive market growth.
Africa's market reached USD 0.05 billion in 2025. Improving healthcare access, increasing awareness of venous disorders, expanding vascular treatment services, and rising investments in healthcare infrastructure continue to create long-term growth opportunities across the region.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com